Radiation Oncology Journal

  • 제28권1호
  • /
  • Pages.16-22
  • /
  • 2010
  • /
  • 2234-1900(pISSN)
  • /
  • 2234-3156(eISSN)
대한방사선종양학회 (The Korean Society for Radiation Oncology)
권호 표지
DOI QR코드

DOI QR Code

방사선 치료를 받은 유방암 환자의 방사선 피부염 발생 정도 및 관련 인자들의 분석

An Analysis of the Incidence and Related Factors for Radiation Dermatitis in Breast Cancer Patients Who Received Radiation Therapy

  • 이선영 (전북대학교병원 방사선종양학과) ;
  • 권형철 (전북대학교병원 방사선종양학과) ;
  • 김정수 (전북대학교병원 방사선종양학과) ;
  • 이희관 (예수병원 방사선종양학과)
  • Lee, Sun-Young (Department of Radiation Oncology, Chonbuk National University Hospital) ;
  • Kwon, Hyoung-Cheol (Department of Radiation Oncology, Chonbuk National University Hospital) ;
  • Kim, Jung-Soo (Department of Radiation Oncology, Chonbuk National University Hospital) ;
  • Lee, Heui-Kwan (Department of Radiation Oncology, Prebyterian Medical Center)
  • 투고 : 2009.12.10
  • 심사 : 2010.01.14
  • 발행 : 2010.08.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

목 적: 방사선치료를 받은 유방암 환자에서 치료로 인한 방사선 피부염의 발생을 감소시킬 수 있는지 알아보기 위해서 전단계로서 피부염 발생정도와 이와 관련된 인자들을 분석해 보았다. 대상 및 방법: 2007년 1월부터 2009년 6월까지 전북대병원 방사선종양학과에서 근치적 목적의 유방 보존 절제술 및 방사선 치료를 받은 침윤성 유방암 환자 338명 중, 보상체를 사용하거나 반대측 유방의 방사선 치료 기왕력이 있는 환자를 제외한 284명에서, 전자선 추가 치료를 시행하기 전 전체 유방에 50 Gy 방사선 조사 후, 방사선 피부염이 발생된 정도와 Radiation Therapy Oncology Group (RTOG) 2도 이상의 중증 피부염을 보인 환자에서 발생 정도에 영향을 미칠 수 있는 요인들을 분석하였다. 결 과: RTOG 등급 0 또는 1과 2도 이상의 경증 및 중증 방사선 피부염은 각각 207명과 77명에서 관찰되었다. 2도 이상 중등도 이상의 방사선 피부염이 발생한 77명의 환자에서 림프액 저류에 의한 림프낭과 림프부종은 방사선 피부염의 회복을 방해하는데 관련된 요소로 분석되었으며 각각 통계적으로 유의한 수준을 나타냈다(p=0.003, p=0.001). 그리고 피부 면역세포 및 사이토카인 활성화에 의한 반창고 과민반응과 호르몬치료 병용도 피부에 영향을 미치는 관련요소로 분석되었으며 각각 통계학적으로 유의한 수준을 나타냈다(p=0.001, p=0.025). 결 론: 방사선치료를 받은 대부분의 유방암 환자에서 경증 또는 중증 정도의 방사선 피부염이 발생되었으며, 림프낭, 림프부종 및 반창고 과민반응 등은 방사선 피부염의 정도에 통계학적으로 유의한 수준의 영향을 미치는 요소로 분석되었다. 따라서 림프낭이 존재하는 경우 방사선치료 전 제거가 우선되어야 하며, 반창고 과민반응이 있는 환자의 경우 치료 중 주의 깊은 관찰과 특히 중등도 이상의 피부염 환자들에게는 치료부위의 피부에 대한 지속적인 보습 교육이 필요하다고 본다.

Purpose: We analyzed the incidence and related factors of radiation dermatitis; at first, to recognize whether a decrease in radiation dermatitis is possible or not in breast cancer patients who received radiation therapy. Materials and Methods: Of 338 patients, 284 with invasive breast cancer who received breast conservation surgery with radiotherapy at Chonbuk National University Hospital from January 2007 to June 2009 were evaluated. Patients who also underwent bolus, previous contralateral breast irradiation and irradiation on both breasts were excluded. For patients who appeared to have greater than moderate radiation dermatitis, the incidence and relating factors for radiation dermatitis were analyzed retrospectively. Results: A total of 207 and 77 patients appeared to have RTOG grade 0/1 or above RTOG grade 2 radiation dermatitis, respectively. The factors found to be statistically significant for the 77 patients who appeared to have greater than moderate radiation dermatitis include the presence of lymphocele due to the stasis of lymph and lymph edema which affect the healing disturbance of radiation dermatitis (p=0.003, p=0.001). Moreover, an allergic reaction to plaster due to the immune cells of skin and the activation of cytokine and concomitant hormonal therapy were also statistically significant factors (p=0.001, p=0.025). Conclusion: Most of the breast cancer patients who received radiation therapy appeared to have a greater than mild case of radiation dermatitis. Lymphocele, lymphedema, an allergy to plaster and concomitant hormonal therapy which affect radiation dermatitis were found to be significant factors. Consequently, we should eliminate lymphocele prior to radiation treatment for patients who appear to have an allergic reaction to plaster. We should also instruct patients of methods to maintain skin moisture if they appear to have a greater than moderate case of radiation dermatitis.

키워드

참고문헌

  1. Central Cancer Registry Center. Annual Report of the Central Cancer in Korea: 2005.01-2007.12. Seoul; Ministry for Health, Welfare and Family Affairs, 2010
  2. Haffty BG, Buchholz TA, Perez CA. Early stage breast cancer. In: Halperin EC, Perez CA, Brady LW, eds. Principles and Practice of Radiation Oncology. 5th ed. Philadelphia, Lippincott Williams & Wilkins. 2007:1175-1291
  3. Ha CC, Lee MZ. Radiation therapy for operable breast cancer after conservative surgery. J Korean Soc Ther Radiol Oncol 2002;20:309-315
  4. Hiraoka M, Mitsumori M, Kokubo M. The Roles and Controversies of Radiation Therapy in Breast Conserving Therapy for Breast Cancer. Breast Cancer 1997;4:127-133 https://doi.org/10.1007/BF02967066
  5. Harper JL, Franklin LE, Jenrette JM, Aguero EG. Skin toxicity during breast irradiation: pathophysiology and management. South Med J 2004;97:989-993 https://doi.org/10.1097/01.SMJ.0000140866.97278.87
  6. Lopez E, Nunez MI, Guerrero MR, et al. Breast cancer acute radiotherapy morbidity evaluated by different scoring systems. Breast Cancer Res Treat 2002;73:127-134 https://doi.org/10.1023/A:1015296607061
  7. Jill Stein. Postmastectomy radiation may cause skin toxicity and pain. In: 13th Annual Meeting of the European Cancer conference; 2005 Oct 31; Paris, France
  8. Collen EB, Mayer MN. Acute effects of radiation treatment: skin reactions. Can Vet J 2006;47:931-935
  9. Fujishiro S, Mitsumori M, Kokubo M, et al. Cosmetic results and complications after breast conserving therapy for early breast cancer. Breast Cancer 2000;7:57-63 https://doi.org/10.1007/BF02967189
  10. Rosen EM, Fan S, Rockwell S, Goldberg ID. The molecular and cellular basis of radiosensitivity: implications for understanding how normal tissues and tumors respond to therapeutic radiation. Cancer Invest 1999;17:56-72 https://doi.org/10.1080/07357909909011718
  11. Turesson I, Nyman J, Holmberg E, Oden A. Prognostic factors for acute and late skin reactions in radiotherapy patients. Int J Radiat Oncol Biol Phys 1996;36:1065-1075 https://doi.org/10.1016/S0360-3016(96)00426-9
  12. Andreassen CN, Alsner J, Overgaard M, Overgaard J. Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes. Radiother Oncol 2003;69:127-135 https://doi.org/10.1016/j.radonc.2003.09.010
  13. Isomura M, Oya N, Tachiiri S, et al. IL12RB2 and ABCA1 genes are associated with susceptibility to radiation dermatitis. Clin Cancer Res 2008;14:6683-6689 https://doi.org/10.1158/1078-0432.CCR-07-4389
  14. Fisher J, Scott C, Stevens R, et al. Randomized phase III study comparing Best Supportive Care to Biafine asa prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation Therapy Oncology Group (RTOG) 97-13. Int J Radiat Oncol Biol Phys 2000;48: 1307-1310 https://doi.org/10.1016/S0360-3016(00)00782-3
  15. Wickline MM. Prevention and treatment of acute radiation dermatitis: a literature review. Oncol Nurs Forum 2004;31:237-247 https://doi.org/10.1188/04.ONF.237-247
  16. Walker VA. Skin care during radiotherapy. Nurs Times 1982;78:2068-2070
  17. Meeren AV, Bertho JM, Vandamme M, Gaugler MH. Ionizing radiation enhances IL-6 and IL-8 production by human endothelial cells. Mediators Inflamm 1997;6:185-193 https://doi.org/10.1080/09629359791677
  18. Merchant TE, Bosley C, Smith J, et al. A phase III trial comparing an anionic phospholipid-based cream and aloe vera-based gel in the prevention of radiation dermatitis in pediatric patients. Radiat Oncol 2007;2:45 https://doi.org/10.1186/1748-717X-2-45
  19. Muller K, Meineke V. Radiation-induced alterations in cytokine production by skin cells. Exp Hematol 2007;35:96-104
  20. Dooms-Goossens A, Boden G, Aupaix F, Bruze M. Allergic contact dermatitis from adhesive plaster due to colophony and epoxy resin. Contact Dermatitis 1993;28:120-121 https://doi.org/10.1111/j.1600-0536.1993.tb03363.x
  21. Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature 2008;453:314-321 https://doi.org/10.1038/nature07039
  22. Pignol JP, Olivotto I, Rakovitch E, et al. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol 2008;26:2085-2092 https://doi.org/10.1200/JCO.2007.15.2488
  23. Primavera G, Carrera M, Berardesca E, et al. A double-blind, vehicle-controlled clinical study to evaluate the efficacy of MAS065D (XClair), a hyaluronic acid-based formulation, in the management of radiation-induced dermatitis. Cutan Ocul Toxicol 2006;25:165-171 https://doi.org/10.1080/15569520600860009

피인용 문헌

  1. Evaluations and Comparisons of Body Surface Doses during Breast Cancer Treatment by Tomotherapy and LINAC Radiotherapy Devices vol.28, pp.4, 2010, https://doi.org/10.14316/pmp.2017.28.4.218